Clinical Channel
Webinars



The Intuitive Clinical Channels are your webinar resource for expanding da Vinci clinical knowledge
and hearing valuable insights from your peers.

Click on the tiles below to register for an upcoming webinar.

Register

Intro goes here

By submitting my information, I am agreeing to receive information regarding Intuitive products and services and related topics. More information may be found in our privacy policy.

Download brochure
“Experienced Approaches to Emergent Colon Resections with da Vinci”
Thursday, December 5, 2024
Register ->
Speakers: Morgan Crigger, MD
Laila Rashidi, MD, FACS, FASCRS

“Empowering Excellence: Unveiling the Value of da Vinci 5 in Gynecology”
Thursday, December 19, 2024
Register ->
Speakers: Richard Farnam, MD



The physician(s) has (have) received compensation from Intuitive for consulting and/or educational services.

For product intended use and/or indications for use, risks, cautions, and warnings and full prescribing information, refer to the associated user manual(s) or visit https://manuals.intuitivesurgical.com/market. For summary of the risks associated with surgery refer to www.intuitive.com/safety.

The material presented represents the views, experiences, and opinions of independent physicians based on their practice and personal experience using Intuitive technology. Their experience may or may not be reproducible and is not generalizable.

Da Vinci 5 System

Contraindication
Use of the force feedback needle driver is contraindicated in hysterectomy and myomectomy due to the risk of vaginal bleeding requiring hospital readmission and/or the need for additional procedures. The use of non-force feedback needle drivers is recommended for suturing in these procedures.

Precaution for Representative Uses
The demonstration of safety and effectiveness for the representative-specific procedures was based on evaluation of the device as a surgical tool and did not include evaluation of outcomes related to the treatment of cancer (overall survival, disease-free survival, local recurrence) or treatment of the patient’s underlying disease or condition. Device usage in all surgical procedures should be guided by the clinical judgment of an adequately trained surgeon.

Da Vinci Xi/X Systems

The demonstration of safety and effectiveness for the representative specific procedures did not include evaluation of outcomes related to the treatment of cancer (overall survival, disease-free survival, local recurrence), except for radical prostatectomy which was evaluated for overall survival, or treatment of the patient’s underlying disease/condition. Device usage in all surgical procedures should be guided by the clinical judgment of an adequately trained surgeon.

Da Vinci SP System

The safety and effectiveness of this device for use in the performance of general laparoscopic surgery procedures have not been established. This device is only intended to be used for single port urological and general thoracoscopic surgical procedures and for transoral otolaryngology surgical procedures in the oropharynx for benign tumors and malignant tumors classified as T1 and T2 with the da Vinci EndoWrist SP Instruments and the da Vinci SP Surgical System (SP1098).

This site uses cookies for personalization, measuring site traffic, and providing an optimal user experience. Click 'Accept' to opt into this enhanced experience or 'Reject' to reject all cookies except essential cookies required for the website to function.